ESC 365
ESC 365
Sign in

    Back

    Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: pro.

    26 August 2022 (14:00 - 14:20)
    Organised by:
    Congress Presentation Part of: Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

    Video

    Sign in for access options

    Slides

    Sign in for access options

    About the speaker

    Photo
    Doctor Carlos Aguiar

    Hospital Santa Cruz, Lisbon (Portugal)

    2 More presentations in this session

    Presentation thumbnail
    Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: con.
    Professor J. Cleland (Glasgow, GB)
    Slides Video
    Presentation thumbnail
    Time to say goodbye to aspirin in cardiovascular disease prevention? – the final word.
    Video

    Access the full session

    Session thumbnail
    Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention?
    Video

    The Event

    Event poster

    ESC Congress 2022

    26 August 2022 14:00 CET
    You may be interested in
    thumbnail
    Webinar
    Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
    Logo
    thumbnail
    Congress Presentation
    Outcomes of diabetic patients with acute coronary syndromes treated with aspirin in primary prevention
    Logo
    thumbnail
    Congress Presentation
    Aspirin does not not associate with lower risk of major cardiovascular events or increased risk of bleeding in older individuals undergoing cardiac computed tomography angiography
    Logo